Insider buying last 90 days
No open-market insider purchases were filed for A in the last 90 days.
From Form 4 filings, dated to when each was filed.
Close on Sep 18, 2026. Page updated Sep 19, 9:19 pm ET.
Agilent (A) closes at $156.47, up 0.1%, holding above both its 50-day ($145.43) and 200-day ($131.55) moving averages, with the 50-day above the 200-day. The GekkoIndex reads 50.5, placing the stock in the Neutral zone, though the index has slipped 9.9 over five days. Price sits 20.3% above Gekko Fair Value of $130.05, a gap that has widened alongside the stock's 40% six-month and 23.5% one-year returns.
This week's news centers on product and shareholder-return activity rather than results. Agilent launched the S540MD, an FDA-cleared digital pathology slide scanner built with Hamamatsu hardware, aimed at helping labs digitize workflows ahead of AI adoption. Separately, the company declared and then corrected a quarterly cash dividend of 25.5 cents per share, to be paid 28 October 2026 to shareholders of record as of 6 October 2026. Management is also scheduled to speak at the J.P. Morgan U.S. All Stars Conference on 23 September 2026.
The next earnings date falls on 23 November 2026, 64 days out and beyond a typical 20-trading-day window; the prior quarter's EPS of $1.49 beat estimates of $1.41 and drove a 17.6% reaction. Analyst consensus among 15 firms stands at 12 buy and 3 hold ratings, with a $174.95 price target implying 11.8% upside. Seasonality over five years shows a 0.5% average 20-day return from this point, positive in 3 of those years. No insider, Congress, or unusual options activity appears in the current windows.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Agilent Technologies scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
Above 50 and 200-day
Close $156.47 is above the 50-day ($145.43) and 200-day ($131.55) averages, and the 50-day is above the 200-day.
See the chart50.5, Neutral
Reading 50.5 is in the Neutral zone.
See the GekkoIndex20.3% above
Price is 20.3% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 64 days
Next report Nov 23, 2026, 64 days away — outside a typical 20-trading-day hold.
See earnings+0.5% on average
From this point in the calendar, the next 20 trading days averaged +0.5% over 5 years, rising in 3 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Agilent Technologies closed at $156.47 on Sep 18, 2026, +23.5% over the past year, inside a 52-week range of $108.35 to $163.75.
Use the left and right arrow keys to read daily values.
Put A on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Agilent Technologies builds instruments, consumables and software used for laboratory analysis in life sciences, diagnostics and applied chemistry. It is best known for chromatography and mass spectrometry equipment, including liquid and gas chromatography systems that pair with mass spectrometry for detailed chemical analysis, along with spectroscopy tools such as inductively coupled plasma, atomic absorption and Raman instruments. Its catalog also covers cell analysis equipment like flow cytometers, imaging systems and microplate readers, plus lab software and automation tools.
The company organizes its work into three areas. One supplies the broad instrumentation and lab automation portfolio described above. Another, focused on diagnostics and genomics, makes arrays and sequencing-related products for genetic testing, tools for DNA and gene expression analysis, tissue staining products, custom oligonucleotides, and reagents and consumables used in nucleic acid quality control. The third, Agilent CrossLab, supplies chromatography columns, sample preparation products, chemical formulations and other consumables and services that support laboratory instruments.
Agilent Technologies trades on the NYSE under the ticker A.
Agilent Technologies’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 50.5, in the Neutral zone, down 9.9 points over five sessions.
Down 9.9 points over five sessions, from the Accumulation zone.
Reading for Sep 18, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 36 | +0.2% | −3.0% | ||
| Accumulation | 207 | 0.0% | +1.3% | ||
| Neutral (current zone) | 370 | +0.4% | +1.4% | ||
| Distribution | 48 | −0.7% | −3.8% | ||
| Selling | 1 | Too few readings yet | |||
Average A share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.2% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Agilent Technologies trades 20.3% above Gekko Fair Value of $130.05, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Agilent Technologies shares are worth, recalculated every trading day.
$130.05
Gekko Fair Value, Sep 19, 2026
20.3% Overvalued
No open-market insider purchases were filed for Agilent Technologies, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for A in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in A were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Agilent Technologies has been buying back its own shares.
From company filings.
2of the funds Gekko tracks hold A.
Agilent Technologies reports on Nov 23, 2026, after the close (64 days away), and beat the EPS estimate in 6 of its last 8 reports.
Nov 23, 2026
Expected after the close, 64 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| May 27, 2026 | $1.49 est $1.41 | $1.84B est $1.80B | +17.6% |
| Feb 25, 2026 | $1.36 est $1.37 | $1.80B est $1.81B | −2.8% |
| Nov 24, 2025 | $1.59 est $1.58 | $1.84B est $1.83B | +3.9% |
| Aug 27, 2025 | $1.37 est $1.37 | $1.74B est $1.68B | +5.6% |
| May 28, 2025 | $1.31 est $1.26 | $1.67B est $1.63B | +1.8% |
| Feb 26, 2025 | $1.31 est $1.27 | $1.68B est $1.67B | −5.3% |
| Nov 25, 2024 | $1.46 est $1.41 | $1.70B est $1.67B | +0.4% |
| Aug 21, 2024 | $1.32 est $1.26 | $1.58B est $1.56B | +0.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Agilent Technologies is $174.95, +11.8% from the last close, from 15 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 15 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 17 | Jefferies | $181 | +15.7% |
| Sep 11 | Jefferies | $155 | −0.9% |
| Sep 9 | Bernstein | $180 | +15.0% |
| Sep 9 | UBS | $165 | +5.5% |
| Sep 2 | Jefferies | $155 | −0.9% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 19, Agilent Technologies averaged +0.5% across the last 5 years, rising in 3 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −2.5% | 1 of 5 |
| Next 10 trading days | +0.3% | 2 of 5 |
| Next 15 trading days | −0.6% | 3 of 5 |
| Next 20 trading days | +0.5% | 3 of 5 |
| Next 30 trading days | 0.0% | 2 of 5 |
For scale, A’s typical 20-trading-day move in either direction is about 5.5%.
Agilent Technologies’s market cap is $44.19B, with a P/E ratio of 30.8 and revenue of $7.37B over the last twelve months.
Coverage of Agilent Technologies this week reads positive: 5 positive, 1 neutral and 0 negative headlines.
Agilent Technologies’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| TMOThermo Fisher Scientific | Distribution | 17.1% above |
| ABTAbbott Laboratories | Accumulation | 15.5% below |
| DHRDanaher | Neutral | 1.1% above |
| ISRGIntuitive Surgical | Neutral | 12.3% above |
| MDTMedtronic | Neutral | 24.7% below |
| SYKStryker | Buying | 17.1% below |
A peer links to its own page where one exists.
Agilent Technologies’s market cap is $44.19B at the Sep 18, 2026 close of $156.47, with 282.0M shares outstanding. The shares trade on a P/E ratio of 30.8.
The consensus analyst 12-month price target for Agilent Technologies is $174.95, +11.8% from the last close. Of the 15 firms that rated the stock in the last 90 days, 12 rate it a buy, 3 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Agilent Technologies is overvalued: the Sep 18, 2026 close of $156.47 is 20.3% above Gekko Fair Value of $130.05. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Agilent Technologies is expected to report on Nov 23, 2026, after the market closes (64 days away). Analysts expect earnings of $1.72 per share on revenue of $1.99B. Agilent Technologies beat the earnings estimate in 6 of its last 8 reports, moving 4.7% on average across the report.
Agilent Technologies’s 52-week high is $163.75 and its 52-week low is $108.35; it closed at $156.47 on Sep 18, 2026, +23.5% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.